Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Molecular Interventions|October 13, 2006
Salvinorin A: from natural product to human therapeuticsTimothy A Vortherms, Bryan L Roth
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activationTimothy A Vortherms, Val J Watts
Idrugs : the Investigational Drugs Journal|May 21, 2005
Receptorome screening for CNS drug discoveryTimothy A Vortherms, Bryan L Roth
Molecular Pharmacology|September 14, 2004
Using molecular tools to dissect the role of Galphas in sensitization of AC1Timothy A Vortherms, Chau H Nguyen, Catherine H Berlot, et al.
The Journal of Biological Chemistry|November 24, 2006
Differential helical orientations among related G protein-coupled receptors provide a novel mechanism for selectivity. Studies with salvinorin A and the kappa-opioid receptorTimothy A Vortherms, Philip D Mosier, Richard B Westkaemper, et al.
Neuropharmacology|December 27, 2005
D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independentTimothy A Vortherms, Chau H Nguyen, Murat Bastepe, et al.
The Journal of Organic Chemistry|November 19, 2005
Autoxidation of salvinorin A under basic conditionsThomas A Munro, Glenn W Goetchius, Bryan L Roth, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2007
In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical seriesDiana L Nersesian, Lawrence A Black, Thomas R Miller, et al.
Biochemistry|June 15, 2005
Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptorsFeng Yan, Philip D Mosier, Richard B Westkaemper, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2012
Discovery of diphenyl lactam derivatives as N-type calcium channel blockersGeorge A Doherty, Pramila Bhatia, Timothy A Vortherms, et al.
Pageof 3